Jaclyn Winter and Shiladitya DasSarma will discuss how they harness the unique biology of extremophiles for the discovery and development of new therapeutics.

The authors propose that the shots might keep the immune system primed to battle diseases that would otherwise contribute to cognitive decline.

Intelligence officials from the US, UK, and Canada point the finger at Cozy Bear, a group with links to the Russian government.

How llamas and superglue might lead to antiviral therapies

James R. Heath, PhD, President of the Institute for Systems Biology will discuss key single-cell learnings and applications from the large Seattle-based academic pharmaceutical consortium committed to defining molecular mechanisms of SARS-CoV-2 infection and identifying potential prognostic immune biomarkers. Stacey Willard, PhD, from IsoPlexis will discuss how functional phenotyping individual immune cells using IsoPlexis technology edges researchers closer to predicting the risk for severe disease. 

How an experimental preparation technique could make vaccines easier to transport, store, and administer

A novel preparation technique could facilitate vaccine preservation, transportation, and administration.

The idea of deliberately infecting volunteers with SARS-CoV-2 has garnered significant attention as a potential avenue to speedier development, as the World Health Organization weighs in with recommendations.

The study, conducted in Malawi, Kenya, and Ghana, did not obtain informed consent from each parent whose child participated, but rather considered consent “implied” because of the particular experimental design.